Human ARHGDIG, a GDP-dissociation inhibitor for Rho proteins: Genomic structure, sequence, expression analysis, and mapping to chromosome 16p13.3

Genomics

Volumn 53, Issue 1, 1998, Pages 104-109

  Adra, Chaker N ^a   Iyengar, Anand R ^a   Syed, Farzand A ^a   Kanaan, Imaduddin N ^a   Abe, Koji ^d   Rilo, Horacio L R ^c   Yu, Weijiang ^a   Kheraj, Reshma ^a   Lin, Shin R ^a   Horiuchi, Tadashi ^a   Khan, Samira ^a   Weremowicz, Stanislawa ^a   Lim, Bing ^a   Morton, Cynthia C ^a   Higgs, Douglas R ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CHICAGO   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA;

ALPHA THALASSEMIA; ARTICLE; BRAIN; CANCER; CHROMOSOME 16P; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE SEQUENCE; GENE STRUCTURE; HUMAN; KIDNEY POLYCYSTIC DISEASE; MENTAL DEFICIENCY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TUBEROUS SCLEROSIS;

EID: 0032191188     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1998.5482     Document Type: Article

References (20)

1. Adra C. N., Ko J. L., Leonard D., Wirth L. J., Cerione R. A., Lim B. Identification of a novel protein with GDP dissociation inhibitor activity for the Ras-like proteins CDC42s and Rac 1. Genes Chromosomes Cancer. 8:1993;253-261.
2. Adra C. N., Zhu S., Ko J. L., Guillemot J. C., Cuervo A. M., Kobayashi H., Horiuchi T., Lelias J. M., Rowley J. D., Lim B. LAPTM5: A novel lysosomal-associated multispanning membrane protein preferentially expressed in hematopoietic cells. Genomics. 35:1996;328-337.
3. Adra C. N., Manor D., Ko J. L., Zhu S., Horiuchi T., Van Aelst L., Cerione R. A., Lim B. RhoGDIγ: A GDP-dissociation inhibitor for Rho proteins with preferential expression in brain and pancreas. Proc. Natl. Acad. Sci. USA. 94:1997;4270-4284.
4. Brown L., Baer R. HEN1 encodes a 20-kilodalton phosphoprotein that binds an extended E-box motif as a homodimer. Mol. Cell. Biol. 14:1994;1245-1255.
5. Brown L., Espinosa I. E., Le Beau M. M., Siciliano M. J., Baer R. HEN1 and HEN2: A subgroup of basic helix-loop-helix genes that are co-expressed in a human neuroblastoma. Proc. Natl. Acad. Sci. USA. 89:1992;8492-8496.
6. Boguski M. S., McCormick F. Proteins regulating Ras and its relatives. Nature. 366:1993;634-654.
7. Flint J., Thomas K., Micklem G., Raynham H., Clark K., Doggett N. A., King A., Higgs D. R. The relationship between chromosome structure and function at a human telomeric region. Nat. Genet. 15:1997;252-257.
8. Fukumoto Y., Kaibuchi K., Hori Y., Fujiko H., Araki S., Ueda T., Kikuchi A., Takai Y. Molecular cloning and characterization of a novel type of regulatory protein (GDI) for the Rho proteins, Ras p21-like small GTP-binding proteins. Oncogene. 5:1990;1321-1328.
9. Funahashi J., Sekido R., Murai K., Kamachi Y., Kondoh H. Delta-crystallin enhancer binding protein delta EF1 is a zinc finger-homeodomain protein implicated in postgastrulation embryogenesis. Development. 119:1993;433-446.
10. Hall A. Rho GTPases and the actin cytoskeleton. Science. 279:1998;509-514.
11. Hancock J., Hall A. A novel role for RhoGDI as an inhibitor of GAP proteins. EMBO J. 12:1993;1915-1921.
12. Hoyt P. R., Bartholomew C., Davis A. J., Yutzey K., Gamer L. W., Potter S. S., Ihle J. N., Mucenski M. L. The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development. Mech. Dev. 65:1997;55-70.
13. Kudrycki K., Stein-Izsak C., Behn C., Grillo M., Akeson R., Margolis F. L. Olf-1 binding site: Characterization of an olfactory neuron-specific promoter motif. Mol. Cell. Biol. 13:1993;3002-3014.
14. Leonard D., Hart M., Platko J., Eva A., Henzel W., Evans T., Cerione R. A. The identification and characterization of a GDP-dissociation inhibitor for the CDC42Hs protein. J. Biol. Chem. 267:1992;22860-22868.
15. Lelias J. M., Adra C. N., Wulf G. M., Guillemot J. C., Khagad K., Caput D., Lim B. cDNA cloning of a human mRNA preferentially expressed in hematopoietic cells and with homology to a GDP-dissociation inhibitor for the Rho GTP-binding proteins. Proc. Natl. Acad. Sci. USA. 90:1993;1479-1483.
16. Platko J., Leonard D., Adra C. N., Shaw R., Cerione R., Lim B. A single residue can modify target-binding affinity and activity of the functional domain of the Rho-subfamily GDP dissociation inhibitors. Proc. Natl. Acad. Sci. USA. 92:1995;2974-2978.
17. Ricordi C., Tzakis A. G., Carroll P. B., Zeng Y., Rilo H. L. R., Alejandro R., Shapiro R., Fung J. J., Demetris A. J., Mintz D. H., Starzl T. E. Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation. 53:1992;407-414.
18. Scherle P., Behrens T., Staudt L. M. Ly-GDI, a GDP-dissociation inhibitor of the Rho A GTP-binding protein is expressed preferentially in lymphocytes. Proc. Natl. Acad. Sci. USA. 90:1993;7568-7572.
19. Van Aelst L., D'Souza-Schorey C. Rho GTPases and signaling networks. Genes Dev. 11:1997;2295-2322.
20. Zalcman G., Closson V., Camonis J., Honore N., Rousseau-Merck M., Tavitian A., Olofsson B. RhoGDI-3 is a new GDP dissociation inhibitor (GDI). J. Biol. Chem. 271:1996;30366-30374.